Feb 24, 2026, 18:26 PM by Dennis P. Cladis, PhD, and Mario G. Ferruzzi, PhD

Feb 24, 2026, 16:37 PM by Mark Messina, PhD, MS

Feb 24, 2026, 15:23 PM by Kacie Barnes, MCN, RDN

Nov 25, 2025, 20:26 PM by Mark Messina, PhD, MS

Nov 25, 2025, 20:25 PM by Virginia Messina, MPH, RD

Nov 25, 2025, 20:24 PM by Mark Messina, PhD, MS

Nov 25, 2025, 20:23 PM by Mark Messina, PhD, MS

Nov 25, 2025, 19:28 PM by Mark Messina, PhD, MS

Nov 25, 2025, 18:40 PM by Mark Messina, PhD, MS

Aug 27, 2025, 20:37 PM by Ajla Bristina, BS and Naiman Khan, PhD, RD

Aug 27, 2025, 20:18 PM by Mark Messina, PhD, MS

Aug 27, 2025, 19:24 PM by Dr. Jenna Stedman, DCN, RD, CSSD

May 28, 2025, 19:34 PM by Dawn Scheier, a fourth-generation U.S. soybean farmer in Salem, SD

May 28, 2025, 17:50 PM by Dustin Moore, PhD, RD

May 28, 2025, 16:17 PM by Katy Martin Rainey, PhD

Mar 28, 2025, 18:55 PM by James O. Hill, PhD and Holly R. Wyatt, MD

Mar 28, 2025, 18:30 PM by Mark Messina, PhD, MS

Mar 28, 2025, 17:47 PM by Michelle Cardel, PhD, MS, RD, FTOS

Dec 18, 2024, 18:59 PM by Michelle Routhenstein, MS, RD, CDCES, CDN

What you need to know: The type of dietary fat one consumes affects their risk of coronary artery disease. Fat types include trans fats, saturated fats, and unsaturated fats. Research shows that the greatest benefit may be achieved by not only removing saturated fat but also replacing it with unsaturated fat (monounsaturated and polyunsaturated fats). This article shares practical, evidence-based recommendations for swapping sources of saturated fat to unsaturated fat which can lead to improved LDL cholesterol and decreased cardiovascular disease risk.

Dec 18, 2024, 18:18 PM by Martha Anne Belury, PhD, RDN

What you need to know: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD), is common in the U.S. – approximately one in four adults have the condition that usually accompanies central obesity and is a major risk factor for metabolic syndrome and type 2 diabetes. The essential omega-6 fatty acid linoleic acid (LA; 18:2n6) may retard lipid accumulation in the liver; dietary intake of linoleic acid (LA) is inversely associated with mortality in women and with risk of type 2 diabetes mellitus in adults. This article examines observational and intervention studies that show beneficial effects of diets rich in LA, including increases in lean mass and HDL cholesterol, and decreases in trunk fat, C-reactive protein (a marker of inflammation), glucose, and the cardioprotective cytokine adiponectin.